Showing 1 - 14 results of 14 for search 'Amedeo Lonardo', query time: 0.02s
Refine Results
-
1
Resmetirom: Finally, the Light at the End of the NASH Tunnel? by Amedeo Lonardo
Published 2024-02-01
Article -
2
-
3
Liver fibrosis: More than meets the eye by Amedeo Lonardo
Published 2024-07-01
Article -
4
Back to the future: From the history of NAFLD to MAFLD to heterogeneity of disease by Amedeo Lonardo
Published 2021-10-01
Article -
5
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition? by Amedeo Lonardo
Published 2021-01-01
Article -
6
-
7
Extra-hepatic cancers in metabolic fatty liver syndromes by Amedeo Lonardo
Published 2023-02-01
Article -
8
-
9
-
10
History of Nonalcoholic Fatty Liver Disease by Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad
Published 2020-08-01
Article -
11
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? by Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Published 2024-01-01
Article -
12
-
13
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Tria... by Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, Giovanni Targher
Published 2021-01-01
Article -
14
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease by Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo
Published 2021-01-01
Article